Company Overview

PRIME exits® and American Healthcare Capital are proud to exclusively represent a Medicare-certified hospice platform for sale that was built around responsive clinical operations, rapid discharge coordination, and repeatable processes rather than daily owner involvement. The seller reports no owner salary burden, a recently signed management-services agreement intended to further offload administrative oversight, and an existing hospital-based general inpatient/respite relationship. Revenue was approximately $2.30 million in FY2025 and is projected to be $2.50 million in 2026 with strong operating profitability. Management reports that the Company is currently operating below Medicare hospice cap limits, and it recently passed its survey with no ADRs.

Financial Snapshot

The Company has shown strong financial improvement over the past three years, with revenue growing from $1.53 million in 2023 to $2.30 million in 2025. While revenue was stable in 2025, profitability expanded significantly. Net income increased from $230,000 to $600,000, and EBITDA grew from $250,000 to $640,000, with margins improving from 16.5% to 27.8%. This trend reflects increasing operating efficiency and margin expansion as the business has scaled.

Why This Opportunity Resonates

• Absentee-owner/owner-light operating model with minimal involvement

• Meaningful profitability with improving margins from FY2023 through FY2025.]

• Established clinical responsiveness, referral relationships, and repeat-care reputation

• Clear runway to accelerate growth through branding, census development, capital support, and additional management depth

• Potential fit for owner-operators, regional strategics, and sponsor-backed hospice platforms comfortable with transition planning around physician coverage

Payor Mix, Census, and Admission

The business consists of 100% Medicare revenue, and Medicaid approval was recently obtained. The average census is 37-42 patients with 4-10 new admissions per month. The average length of stay is 100 days.

Seller Positioning

The seller is seeking a buyer prepared to support the next phase of growth, either as a more involved owner-operator or as a strategic/platform investor able to add capital and management depth. Current medical-director transition planning would be part of deal structuring if a buyer elects not to retain the existing physician. The existing staff of 25 is expected to remain post-closing.

Asking Price

The asking price for this well-operated hospice with minimal owner involvement is $5.0 Million. The Seller will consider a majority sale and roll-over equity if the buyer is qualified with experience in scaling. The asking price is for 100% of the enterprise value, and debt-free. It excludes cash, accounts receivable, working capital, and any real property.